← Every company
Relay Therapeutics Inc Patents
What Relay Therapeutics Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
RLAY on carbonthat →Filings on file
17
Granted
0
Still pending
17
Filed under
2 names
17 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOFA61P 35/00, C07C 211/29, C07C2601/08, C07C2602/18, C07C2602/42, C07C2601/02, A61K 31/137, A61K 31/325, A61K 31/403, A61K 31/4184, A61K 31/423, C07C 215/68, C07C 233/13, C07C 235/06, C07C 235/26, C07C 235/40, C07C 237/24, C07C 255/46, C07C 271/06, C07C 271/24, C07C 275/24, C07C 275/26, C07C 275/32, C07C 275/42, C07C 311/08, C07C 311/47, C07C 317/44, C07D 205/04, C07D 207/22, C07D 207/27, C07D 207/337, C07D 209/08, C07D 209/54, C07D 209/96, C07D 211/58, C07D 213/75, C07D 215/38, C07D 231/12, C07D 231/38, C07D 233/64, C07D 233/74, C07D 235/02, C07D 235/30, C07D 237/08, C07D 237/20, C07D 237/24, C07D 239/28, C07D 239/48, C07D 239/70, C07D 243/08, C07D 263/52, C07D 271/10, C07D 277/38, C07D 277/82, C07D 295/26, C07D 307/14, C07D 307/84, C07D 333/72, C07D 335/02, C07D 401/04, C07D 401/06, C07D 401/14, C07D 403/04, C07D 403/14, C07D 405/12, C07D 405/14, C07D 409/12, C07D 413/04, C07D 413/06, C07D 417/04, C07D 417/12, C07D 471/04, C07D 487/04Filed as Relay Therapeutics, Inc.2025-08-11Yue Pan | pending |
| PI3K INHIBITORS AND METHODS OF MAKING AND USING THE SAMEFiled as Relay Therapeutics, Inc.2025-07-10Qinglin Che | pending |
| CDK INHIBITORS AND METHODS OF USE THEREOFC07D 401/04, C07D 417/14, A61P 35/00, A61K 31/437, A61K 31/4375, A61K 31/4433, A61K 31/4436, A61K 31/4439, A61K 31/444, A61K 31/4545, A61K 31/4709, A61K 31/4725, A61K 31/496, A61K 31/4985, A61K 31/501, A61K 31/505, A61K 31/506, A61K 31/513, A61K 31/517, A61K 31/519, A61K 31/52, A61K 31/53, A61K 31/5377, A61K 31/538, A61K 31/5386, A61K 31/55, A61K 31/551, A61K 31/553, A61K 31/675, C07B 59/002, C07D 239/42, C07D 401/14, C07D 403/04, C07D 403/14, C07D 405/04, C07D 405/12, C07D 405/14, C07D 409/14, C07D 411/14, C07D 413/12, C07D 413/14, C07D 471/04, C07D 471/10, C07D 471/14, C07D 471/20, C07D 473/34, C07D 487/04, C07D 487/08, C07D 487/10, C07D 487/20, C07D 491/04, C07D 491/048, C07D 491/08, C07D 491/107, C07D 491/20, C07D 493/04, C07D 493/10, C07D 495/04, C07D 498/08, C07D 498/14, C07D 513/04, C07D 513/14, C07D 519/00, C07F 9/65586, C07F 9/65685Filed as Relay Therapeutics, Inc.2025-05-23Jing He | pending |
| SOLID FORMS OF A CDK INHIBITORA61K 31/4155, C07D 405/14, A61P 35/00, C07B2200/13, C07C 55/10, C07C 59/08, C07C 59/245, C07C 59/255, C07C 63/08Filed as Relay Therapeutics, Inc.2025-02-04Andre Lescarbeau | pending |
| PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOFFiled as RELAY THERAPEUTICS, INC.2025-01-31AMAEL MADEC | pending |
| ESTROGEN RECEPTOR ALPHA DEGRADERS AND METHODS OF USE THEREOFC07D 401/14, A61K 47/55, A61P 35/00, A61K 31/4545, A61K 31/496, C07D 211/88, C07D 401/04, C07D 401/12, C07D 405/12, C07D 405/14, C07D 451/02, C07D 471/04, C07D 471/10, C07D 487/04, C07D 487/08, C07D 487/10, C07D 491/107, C07D 491/20, C07D 493/08, C07D 493/10, C07D 495/10, C07D 498/10, C07D 498/20, C07F 5/025Filed as Relay Therapeutics, Inc.2024-12-27Alexander M. Taylor | pending |
| PI3KA INHIBITORS AND METHODS OF MAKING AND USING THE SAMEFiled as RELAY THERAPEUTICS, INC.2024-11-15VISHNU VARDHAN REDDY KARNATI | pending |
| PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOFA61P 35/00, C07C 211/29, C07C2601/08, C07C2602/18, C07C2602/42, C07C2601/02, A61K 31/137, A61K 31/325, A61K 31/403, A61K 31/4184, A61K 31/423, C07C 215/68, C07C 233/13, C07C 235/06, C07C 235/26, C07C 235/40, C07C 237/24, C07C 255/46, C07C 271/06, C07C 271/24, C07C 275/24, C07C 275/26, C07C 275/32, C07C 275/42, C07C 311/08, C07C 311/47, C07C 317/44, C07D 205/04, C07D 207/22, C07D 207/27, C07D 207/337, C07D 209/08, C07D 209/54, C07D 209/96, C07D 211/58, C07D 213/75, C07D 215/38, C07D 231/12, C07D 231/38, C07D 233/64, C07D 233/74, C07D 235/02, C07D 235/30, C07D 237/08, C07D 237/20, C07D 237/24, C07D 239/28, C07D 239/48, C07D 239/70, C07D 243/08, C07D 263/52, C07D 271/10, C07D 277/38, C07D 277/82, C07D 295/26, C07D 307/14, C07D 307/84, C07D 333/72, C07D 335/02, C07D 401/04, C07D 401/06, C07D 401/14, C07D 403/04, C07D 403/14, C07D 405/12, C07D 405/14, C07D 409/12, C07D 413/04, C07D 413/06, C07D 417/04, C07D 417/12, C07D 471/04, C07D 487/04Filed as Relay Therapeutics, Inc.2024-11-06Yue Pan | pending |
| FGFR INHIBITORS AND METHODS OF MAKING AND USING THE SAMEC07D 487/04, A61P 35/00, A61K 31/519, C07B2200/13, C07C 309/04, C07C 309/30Filed as Relay Therapeutics, Inc.2024-10-15André Lescarbeau | pending |
| PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOFFiled as Relay Therapeutics, Inc.2024-08-07Amael Madec | pending |
| PI3K-ALPHA INHIBITORS AND METHODS OF MAKING AND USING THE SAMEA61K 45/06, C07D 471/04, A61P 35/00, A61K 31/437, C07C 309/04, C07C 309/30, C07C 309/35Filed as Relay Therapeutics, Inc.2024-05-01André Lescarbeau | pending |
| BIFUNCTIONAL PI3K-ALPHA INHIBITORS AND USES THEREOFA61K 47/55, A61P 35/00, A61K 47/545, C07D 209/46, C07D 401/14, C07D 405/14, C07D 409/12, C07D 409/14, C07D 417/14, C07D 487/04Filed as Relay Therapeutics, Inc.2024-05-01Alessandro BOEZIO | pending |
| PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOFC07D 311/58, C07D 471/04, A61P 35/00, A61K 31/4035, A61K 31/4433, A61K 31/4439, A61K 31/444, A61K 31/453, A61K 31/4545, A61K 31/4725, A61K 31/496, A61K 31/501, A61K 31/506, A61K 31/517, A61K 31/519, A61K 31/536, A61K 31/5377, A61K 31/549, A61K 31/551, A61K 31/553, C07D 215/38, C07D 239/88, C07D 239/91, C07D 239/95, C07D 311/22, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/04, C07D 405/04, C07D 405/06, C07D 405/12, C07D 405/14, C07D 417/12, C07D 487/04, C07D 491/056, C07D 519/00Filed as Relay Therapeutics, Inc.2024-04-04Alessandro BOEZIO | pending |
| JAK2 INHIBITORS AND METHODS OF USE THEREOFC07D 401/14, A61K 31/501, A61K 31/502, A61K 31/506, A61K 31/675, C07D 237/24, C07D 401/12, C07D 403/12, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/12, C07D 417/14, C07D 471/04, C07D 487/04, C07F 9/65583Filed as RELAY THERAPEUTICS, INC.2024-02-20Lucian V. DiPietro | pending |
| PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOFFiled as Relay Therapeutics, Inc.2024-01-31Amael MADEC | pending |
| PI3K INHIBITORS AND METHODS OF MAKING AND USING THE SAMEFiled as RELAY THERAPEUTICS, INC.2024-01-12QINGLIN CHE | pending |
| PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOFFiled as RELAY THERAPEUTICS, INC.2024-01-10Alessandro BOEZIO | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on RLAY
Company overviewEverything on RLAY in one place, with the price.SEC filingsWhat RLAY's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat RLAY's own officers and directors buy and sell.Planned salesSales RLAY insiders have filed notice of.Executive payWhat RLAY awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in RLAY.Funds holding itWhich funds and ETFs hold RLAY, and how big a bet.